Aisling Capital Management LP
Source: SEC Form 13F · as of Mar 2026Aisling Capital Management LP holds 10 biotech & pharma companies tracked by BioSniper, totaling $94.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$94.8M
| Company | Shares | Value |
|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | 1,316,806 | $30.8M |
| GLUEMonte Rosa Therapeutics, Inc. | 1,555,664 | $25.6M |
| BCAXBicara Therapeutics Inc. | 568,919 | $11.3M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 1,018,018 | $9.1M |
| CMPSCOMPASS Pathways plc | 1,432,336 | $7.9M |
| SRRKScholar Rock Holding Corp | 77,031 | $3.8M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 325,000 | $2.4M |
| URGNUroGen Pharma Ltd. | 108,000 | $1.9M |
| ACRSAclaris Therapeutics, Inc. | 434,455 | $1.6M |
| OKUROnKure Therapeutics, Inc. | 88,607 | $367K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.